Harrow
HROW
30.62
+0.27
+0.89%
Harrow
US · HROW
#3155 by market cap
30.62
+0.27
+0.89%
Live - 5344 symbols - heartbeat 528s ago
· 2026-10-08 09:03
Pre-market
30.55
-0.23%
After-hours
31.12
+1.63%
Overnight
30.69
+0.23%
- Market cap
- 1.15B
- P/E (TTM)i
- -30.93
- P/Bi
- 75.60
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on HROW?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)TipRanks · 2026/8/20
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $91Market Newswire · 2026/3/18
-
Rating change
H.C. Wainwright Remains a Buy on Harrow Health (HROW)TipRanks · 2026/5/14
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/8/10
-
Rating change
Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)TipRanks · 2026/8/20
-
Rating change
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 2026/5/12
-
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/10/5
-
Rating change
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI)TipRanks · 2026/8/7
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88Market Newswire · 2026/8/11
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60Market Newswire · 2026/5/14
-
Rating change
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM)TipRanks · 2026/8/11
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65Market Newswire · 2026/4/7
-
Rating change
A Quick Look at Today's Ratings for Harrow(HROW.US), With a Forecast Between $60 to $91Market Newswire · 2026/3/5
-
Rating change
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59Market Newswire · 2026/7/13
-
Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45Market Newswire · 2026/9/9
-
BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63Market Newswire · 2026/8/26
-
Craig-Hallum Maintains Harrow(HROW.US) With Buy RatingMarket Newswire · 2026/9/30
-
Rating change
H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/8/12
-
William Blair Maintains Harrow(HROW.US) With Buy RatingMarket Newswire · 2026/10/5
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88Market Newswire · 2026/5/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:03:56 · For reference only, not investment advice and not tailored to your situation.